Back to today’s briefing

Story perspectives

New Biomarker Predicts Aggressiveness in Meningioma, Breast Cancers

2/14/2025

50 7

Summary

Story summary

A groundbreaking discovery by researchers at Fred Hutch and MD Anderson Cancer Centers reveals that elevated levels of RNA Polymerase II (RNAPII) on histone genes can predict the aggressiveness of meningioma and breast cancers. This promising biomarker could pave the way for enhanced cancer diagnostics and more effective treatment strategies, offering hope for patients facing these challenging diseases.

1 of 1

Story summary

A groundbreaking discovery by researchers at Fred Hutch and MD Anderson Cancer Centers reveals that elevated levels of RNA Polymerase II (RNAPII) on histone genes can predict the aggressiveness of meningioma and breast cancers. This promising biomarker could pave the way for enhanced cancer diagnostics and more effective treatment strategies, offering hope for patients facing these challenging diseases.